Immunoassay controls

• US 6,627,459 B1
• Filed: 04/19/2000
• Issued: 09/30/2003
• Est. Priority Date: 04/19/2000
• Status: Expired due to Term

• Current Assignee: Inverness Medical Switzerland GmbH (Abbott Laboratories Incorporated)
• Original Assignee: Applied Biotech Inc. (Johnson & Johnson)
• Inventors: Huang, He, Tung, Ker-kong
• Primary Examiner(s): Chin, Christopher L.
• Application Number:
  US09/552,397
• Time in Patent Office: 1,259 Days
• Field of Search: 422/55-58, 435/7.1, 435/7.2, 435/7.21, 435/7.32, 435/7.92, 435/287.1, 435/287.9, 435/805, 435/810, 435/970, 436/169, 436/514, 436/518, 436/530, 436/810
• US Class Current: 436/514
• CPC Class Codes: G01N 33/558 using diffusion or migration of antigen or antibody immunochromatographic test strips G01N33/54387
• CPC Class Codes: Y10S 435/805 Test papers
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 435/97 Test strip or test slide
• CPC Class Codes: Y10S 436/81 Tube, bottle, or dipstick

Abstract

A device and method for performing a rapid immunoassay for a biological analyte containing a positive control analyte which is concurrently tested using the same device and immunochemical reaction as the biological analyte. The positive control analyte is non-crossreactive with the biological analyte to be detected and may be an immunogen or a hapten. The device and method permit operators of the test device, particularly non-laboratory professionals, to determine that an assay is performed correctly and that the device is functioning properly, thereby allowing the operator to have confidence in the accuracy of either a positive or negative result. This is particularly important when a positive result is indicated by the absence of color at a test site, which is counterintuitive with many operators and which frequently occurs with a competitive immunoassay.

Claims

1. A test strip for immunoassay of at least one biological analyte in a sample comprising, in order of sample migration, a sample pad, a conjugate pad, a membrane containing a test site wherein the presence of said analyte in said sample is indicated by absence of color formation at said test site, said strip comprising a mobile positive control analyte immunologically distinct from said biological analyte in said sample pad, a labeled antibody specific to said control analyte in said conjugate pad, a labeled antibody specific to at least one of said biological analyte in said conjugate pad, an immobile control analyte at a positive control site in said membrane, and an immobile biological analyte at said test site in said membrane, said test strip indicating immunoassay function by absence of color formation at said control site, and said test strip indicating presence of said biological analyte at said test site by the absence of color formation at said test site.

2. The test strip of claim 1 wherein the control analyte is selected from the group consisting of cotinine, creatinine, digoxin and combinations thereof.

3. The test strip of claim 1 further comprising a negative control analyte.

4. The test strip of claim 1 further comprising a dye at said positive control site.

5. The test strip of claim 1 wherein the antibody has a label selected from the group consisting of an enzyme, a metal sol, a chromophore, a fluorophore and combinations thereof.

6. The test strip of claim 1 contained in a housing.

7. A plurality of the test strips of claim 1 contained in a housing.

8. A test strip for concurrent immunoassay of a biological analyte in a sample and a control analyte by competitive immunoassay, said test strip comprising a sample pad comprising a mobilizable control analyte immunologically distinct from said biological analyte, a conjugate pad comprising a mobilizable labeled antibody to said control analyte and a mobilizable labeled antibody to said biological analyte, and a downstream membrane comprising a discrete region of immobilizable control analyte and a discrete region of immobilized biological analyte.

9. The test strip of claim 8, wherein said control analyte is cotinine.

10. The test strip of claim 8, wherein said biological analyte is at least one drug.

11. The test strip of claim 8, wherein said discrete region of immobilizable control analyte contains a marker dye.